Skip to main content

Advertisement

Log in

Genetics of primary ovarian insufficiency: a review

  • Review
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Primary ovarian insufficiency is one of the main causes of female infertility owing to an abnormal ovarian reserve. Its relevance has increased in more recent years due to the fact that age of motherhood is being delayed in developed countries, with the risk of having either primary ovarian insufficiency or less chances of pregnancy when women consider the option of having their first baby. Several exogenous factors can lead to this event, such us viral infections, metabolomic dysfunction, autoimmune diseases, and environmental or iatrogenic factors, although in most cases the mechanism that leads to the disorder is unknown. Genetic factors represent the most commonly identified cause and the impact of sex chromosome abnormalities (e.g., Turner syndrome or X structural abnormalities), autosomal and X-linked mutations on the genesis of primary ovarian insufficiency has also been well described. Yet in most cases, the genetic origin remains unknown and there are multiple candidate genes. This review aims to collect all the genetic abnormalities and genes associated with syndromic and non syndromic primary ovarian insufficiency that have been published in the literature to date using the candidate-gene approach and a genome-wide analysis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Nelson LM. Clinical practice. Primary ovarian insufficiency. N Engl J Med. 2009;360:606–14.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Visser JA, Schipper I, Laven JS, Themmen AP. Anti-Mullerian hormone: an ovarian reserve marker in primary ovarian insufficiency. Nat Rev Endocrinol. 2012;8:331–41.

    CAS  PubMed  Google Scholar 

  3. De Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet. 2010;376:911–21.

    Article  PubMed  Google Scholar 

  4. Welt CK. Primary ovarian insufficiency: a more accurate term for premature ovarian failure. Clin Endocrinol (Oxf). 2008;68:499–509.

    Article  Google Scholar 

  5. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67:604–6.

    CAS  PubMed  Google Scholar 

  6. Aubuchon M, Santoro N. Lessons learned from the WHI: HRT requires a cautious and individualized approach. Geriatrics. 2004;59:22–6.

    PubMed  Google Scholar 

  7. van Kasteren YM, Hundscheid RD, Smits AP, Cremers FP, van Zonneveld P, Braat DD. Familial idiopathic premature ovarian failure: an overrated and underestimated genetic disease? Hum Reprod. 1999;14:2455–9.

    Article  PubMed  Google Scholar 

  8. Beck-Peccoz P, Persani L. Premature ovarian failure. Orphanet J Rare Dis. 2006;1:9.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Cordts EB, Christofolini DM, Dos Santos AA, Bianco B, Barbosa CP. Genetic aspects of premature ovarian failure: a literature review. Arch Gynecol Obstet. 2011;283:635–43.

    Article  PubMed  Google Scholar 

  10. Simpson JL. Genetic and phenotypic heterogeneity in ovarian failure: overview of selected candidate genes. Ann N Y Acad Sci. 2008;1135:146–54.

    Article  PubMed  Google Scholar 

  11. Chakhtoura Z, Touraine P. Fertility on women with Turner syndrome. Presse Med. 2013;42:1508–12.

    Article  PubMed  Google Scholar 

  12. Fenichel P, Brucker-Davis F. Environmental endocrine disruptors and breast cancer: new risk factors? Gynecol Obstet Fertil. 2008;36:969–77.

    Article  CAS  PubMed  Google Scholar 

  13. Hagman A, Kallen K, Bryman I, Landin-Wilhelmsen K, Barrenas ML, Wennerholm UB. Morbidity and mortality after childbirth in women with Turner karyotype. Hum Reprod. 2013;28:1961–73.

    Article  CAS  PubMed  Google Scholar 

  14. Fenichel P, Letur H. Procreation in Turner’s syndrome: which recommendations before, during and after pregnancy? Gynecol Obstet Fertil. 2008;36:891–7.

    Article  CAS  PubMed  Google Scholar 

  15. Otter M, Schrander-Stumpel CT, Curfs LM. Triple X syndrome: a review of the literature. Eur J Hum Genet. 2010;18:265–71.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Goswami R, Goswami D, Kabra M, Gupta N, Dubey S, Dadhwal V. Prevalence of the triple X syndrome in phenotypically normal women with premature ovarian failure and its association with autoimmune thyroid disorders. Fertil Steril. 2003;80:1052–4.

    Article  PubMed  Google Scholar 

  17. Collen RJ, Falk RE, Lippe BM, Kaplan SA. A 48, XXXX female with absence of ovaries. Am J Med Genet. 1980;6:275–8.

    Article  CAS  PubMed  Google Scholar 

  18. Wood A, Kleis L, Toriello H, Cemeroglu AP. Mosaic pentasomy X/tetrasomy X syndrome and premature ovarian failure. Indian Pediatr. 2011;48:402–4.

    PubMed  Google Scholar 

  19. Simpson JL. Gonadal dysgenesis and abnormalities of the human sex chromosomes: current status of phenotypic-karyotypic correlations. Birth Defects Orig Artic Ser. 1975;11:23–59.

    CAS  PubMed  Google Scholar 

  20. Goswami D, Conway GS. Premature ovarian failure. Hum Reprod Update. 2005;11:391–410.

    Article  CAS  PubMed  Google Scholar 

  21. Persani L, Rossetti R, Cacciatore C. Genes involved in human premature ovarian failure. J Mol Endocrinol. 2010;45:257–79.

    Article  CAS  PubMed  Google Scholar 

  22. Bertini V, Ghirri P, Bicocchi MP, Simi P, Valetto A. Molecular cytogenetic definition of a translocation t(X;15) associated with premature ovarian failure. Fertil Steril. 2010;94:1097.e5–e8.

    Article  Google Scholar 

  23. Bashamboo A, Ravel C, Brauner R, McElreavey K. NR5A1 and ovarian failure. Med Sci (Paris). 2009;25:809–13.

    Article  Google Scholar 

  24. Paliwal P, Sharma A, Birla S, Kriplani A, Khadgawat R, Sharma A. Identification of novel SRY mutations and SF1 (NR5A1) changes in patients with pure gonadal dysgenesis and 46, XY karyotype. Mol Hum Reprod. 2011;17:372–8.

    Article  CAS  PubMed  Google Scholar 

  25. Polakova M, Alexander D, Sulc J, Zetova L, Vlk R, Krepelova A, et al. Pregnancy and delivery in a patient with pure 46, XY karyotype. Summary of actual knowledge about XY women. Ceska Gynekol. 2013;78:443–7.

    CAS  PubMed  Google Scholar 

  26. Wittenberger MD, Hagerman RJ, Sherman SL, McConkie-Rosell A, Welt CK, Rebar RW, et al. The FMR1 premutation and reproduction. Fertil Steril. 2007;87:456–65.

    Article  CAS  PubMed  Google Scholar 

  27. Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, Hills J, et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology. 2001;57:127–30.

    Article  CAS  PubMed  Google Scholar 

  28. Hagerman RJ, Leavitt BR, Farzin F, Jacquemont S, Greco CM, Brunberg JA, et al. Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet. 2004;74:1051–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Utari A, Adams E, Berry-Kravis E, Chavez A, Scaggs F, Ngotran L, et al. Aging in fragile X syndrome. J Neurodev Disord. 2010;2:70–6.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Yang JC, Simon C, Schneider A, Seritan AL, Hamilton L, Hagerman PJ, et al. Abnormal semantic processing in females with fragile X-associated tremor/ataxia syndrome. Genes Brain Behav. 2014;13:152–62.

    Article  CAS  PubMed  Google Scholar 

  31. Yang JC, Simon C, Niu YQ, Bogost M, Schneider A, Tassone F, et al. Phenotypes of hypofrontality in older female fragile X premutation carriers. Ann Neurol. 2013;74:275–83.

    PubMed Central  PubMed  Google Scholar 

  32. Nayot D, Chung JT, Son WY, Ao A, Hughes M, Dahan MH. Live birth following serial vitrification of embryos and PGD for fragile X syndrome in a patient with the premutation and decreased ovarian reserve. J Assist Reprod Genet. 2013;30:1439–44.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Kallinen J, Korhonen K, Kortelainen S, Heinonen S, Ryynanen M. Pregnancy outcome in carriers of fragile X. BJOG. 2000;107:969–72.

    Article  CAS  PubMed  Google Scholar 

  34. Platteau P, Sermon K, Seneca S, Van Steirteghem A, Devroey P, Liebaers I. Preimplantation genetic diagnosis for fragile Xa syndrome: difficult but not impossible. Hum Reprod. 2002;17:2807–12.

    Article  PubMed  Google Scholar 

  35. Murray A, Webb J, Dennis N, Conway G, Morton N. Microdeletions in FMR2 may be a significant cause of premature ovarian failure. J Med Genet. 1999;36:767–70.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  36. Dixit H, Rao L, Padmalatha V, Raseswari T, Kapu AK, Panda B, et al. Genes governing premature ovarian failure. Reprod Biomed Online. 2010;20:724–40.

    Article  CAS  PubMed  Google Scholar 

  37. Chatterjee S, Singh R, Kadam S, Maitra A, Thangaraj K, Meherji P, et al. Longer CAG repeat length in the androgen receptor gene is associated with premature ovarian failure. Hum Reprod. 2009;24:3230–5.

    Article  CAS  PubMed  Google Scholar 

  38. Fonseca DJ, Garzon E, Lakhal B, Braham R, Ojeda D, Elghezal H, et al. Screening for mutations of the FOXO4 gene in premature ovarian failure patients. Reprod Biomed Online. 2012;24:339–41.

    Article  CAS  PubMed  Google Scholar 

  39. Peng C. The TGF-beta superfamily and its roles in the human ovary and placenta. J Obstet Gynaecol Can. 2003;25:834–44.

    PubMed  Google Scholar 

  40. Tachdjian G, Aboura A, Portnoi MF, Pasquier M, Bourcigaux N, Simon T, et al. Cryptic Xp duplication including the SHOX gene in a woman with 46, X, del(X)(q21.31) and premature ovarian failure. Hum Reprod. 2008;23:222–6.

    Article  CAS  PubMed  Google Scholar 

  41. Ghadami M, El-Demerdash E, Salama SA, Binhazim AA, Archibong AE, Chen X, et al. Toward gene therapy of premature ovarian failure: intraovarian injection of adenovirus expressing human FSH receptor restores folliculogenesis in FSHR(−/−) FORKO mice. Mol Hum Reprod. 2010;16:241–50.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. Grynberg M, Peltoketo H, Christin-Maitre S, Poulain M, Bouchard P, Fanchin R. First birth achieved after in vitro maturation of oocytes from a woman endowed with multiple antral follicles unresponsive to follicle-stimulating hormone. J Clin Endocrinol Metab. 2013;98:4493–8.

    Article  CAS  PubMed  Google Scholar 

  43. Arnhold IJ, Latronico AC, Batista MC, Izzo CR, Mendonca BB. Clinical features of women with resistance to luteinizing hormone. Clin Endocrinol (Oxf). 1999;51:701–7.

    Article  CAS  Google Scholar 

  44. Harris SE, Chand AL, Winship IM, Gersak K, Aittomaki K, Shelling AN. Identification of novel mutations in FOXL2 associated with premature ovarian failure. Mol Hum Reprod. 2002;8:729–33.

    Article  CAS  PubMed  Google Scholar 

  45. Roth LW, Alvero R. Pregnancy in a woman with premature ovarian insufficiency associated with blepharophimosis, ptosis, epicanthus inversus syndrome type I. A case report. J Reprod Med. 2014;59:87–9.

    PubMed  Google Scholar 

  46. Gubbels CS, Land JA, Rubio-Gozalbo ME. Fertility and impact of pregnancies on the mother and child in classic galactosemia. Obstet Gynecol Surv. 2008;63:334–43.

    Article  PubMed  Google Scholar 

  47. Fierabracci A, Bizzarri C, Palma A, Milillo A, Bellacchio E, Cappa M. A novel heterozygous mutation of the AIRE gene in a patient with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED). Gene. 2012;511:113–7.

    Article  CAS  PubMed  Google Scholar 

  48. Bhangoo A, Buyuk E, Oktay K, Ten S. Phenotypic features of 46, XX females with StAR protein mutations. Pediatr Endocrinol Rev. 2007;5:633–41.

    PubMed  Google Scholar 

  49. Pellicer A, Miro F, Sampaio M, Gomez E, Bonilla-Musoles FM. In vitro fertilization as a diagnostic and therapeutic tool in a patient with partial 17,20-desmolase deficiency. Fertil Steril. 1991;55:970–5.

    CAS  PubMed  Google Scholar 

  50. Kim S, Pyun JA, Cha DH, Ko JJ, Kwack K. Epistasis between FSHR and CYP19A1 polymorphisms is associated with premature ovarian failure. Fertil Steril. 2011;95:2585–8.

    Article  CAS  PubMed  Google Scholar 

  51. Fogli A, Gauthier-Barichard F, Schiffmann R, Vanderhoof VH, Bakalov VK, Nelson LM, et al. Screening for known mutations in EIF2B genes in a large panel of patients with premature ovarian failure. BMC Womens Health. 2004;4:8.

    Article  PubMed Central  PubMed  Google Scholar 

  52. Kosaki K, Sato S, Hasegawa T, Matsuo N, Suzuki T, Ogata T. Premature ovarian failure in a female with proximal symphalangism and Noggin mutation. Fertil Steril. 2004;81:1137–9.

    Article  PubMed  Google Scholar 

  53. Luoma P, Melberg A, Rinne JO, Kaukonen JA, Nupponen NN, Chalmers RM, et al. Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet. 2004;364:875–82.

    Article  CAS  PubMed  Google Scholar 

  54. Cox L, Liu JH. Primary ovarian insufficiency: an update. Int J Womens Health. 2014;6:235–43.

    PubMed Central  PubMed  Google Scholar 

  55. Demirhan O, Turkmen S, Schwabe GC, Soyupak S, Akgul E, Tastemir D, et al. A homozygous BMPR1B mutation causes a new subtype of acromesomelic chondrodysplasia with genital anomalies. J Med Genet. 2005;42:314–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  56. Simon AM, Goodenough DA, Li E, Paul DL. Female infertility in mice lacking connexin 37. Nature. 1997;385:525–9.

    Article  CAS  PubMed  Google Scholar 

  57. Chand AL, Harrison CA, Shelling AN. Inhibin and premature ovarian failure. Hum Reprod Update. 2010;16:39–50.

    Article  CAS  PubMed  Google Scholar 

  58. Dixit H, Rao KL, Padmalatha VV, Kanakavalli M, Deenadayal M, Gupta N, et al. Mutational analysis of the betaglycan gene-coding region in susceptibility for ovarian failure. Hum Reprod. 2006;21:2041–6.

    Article  CAS  PubMed  Google Scholar 

  59. Bouilly J, Bachelot A, Broutin I, Touraine P, Binart N. Novel NOBOX loss-of-function mutations account for 6.2 % of cases in a large primary ovarian insufficiency cohort. Hum Mutat. 2011;32:1108–13.

    Article  CAS  PubMed  Google Scholar 

  60. Zhao H, Chen ZJ, Qin Y, Shi Y, Wang S, Choi Y, et al. Transcription factor FIGLA is mutated in patients with premature ovarian failure. Am J Hum Genet. 2008;82:1342–8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  61. Watkins WJ, Umbers AJ, Woad KJ, Harris SE, Winship IM, Gersak K, et al. Mutational screening of FOXO3A and FOXO1A in women with premature ovarian failure. Fertil Steril. 2006;86:1518–21.

    Article  CAS  PubMed  Google Scholar 

  62. Qin Y, Vujovic S, Li G, Li J, Dalgleish R, Simpson JL, et al. Ethnic specificity of variants of the ESR1, HK3, BRSK1 genes and the 8q22.3 locus: No association with premature ovarian failure (POF) in Serbian women. Maturitas. 2014;77:64–7.

    Article  CAS  PubMed  Google Scholar 

  63. Liu L, Tan R, Cui Y, Liu J, Wu J. Estrogen receptor alpha gene (ESR1) polymorphisms associated with idiopathic premature ovarian failure in Chinese women. Gynecol Endocrinol. 2013;29:182–5.

    Article  PubMed  Google Scholar 

  64. Gao F, Zhang J, Wang X, Yang J, Chen D, Huff V, et al. Wt1 functions in ovarian follicle development by regulating granulosa cell differentiation. Hum Mol Genet. 2014;23:333–41.

    Article  CAS  PubMed  Google Scholar 

  65. Shimizu Y, Kimura F, Takebayashi K, Fujiwara M, Takakura K, Takahashi K. Mutational analysis of the PTEN gene in women with premature ovarian failure. Acta Obstet Gynecol Scand. 2009;88:824–5.

    Article  CAS  PubMed  Google Scholar 

  66. Ojeda D, Lakhal B, Fonseca DJ, Braham R, Landolsi H, Mateus HE, et al. Sequence analysis of the CDKN1B gene in patients with premature ovarian failure reveals a novel mutation potentially related to the phenotype. Fertil Steril. 2011;95:2658. 60.e1.

    Article  CAS  PubMed  Google Scholar 

  67. Fonseca DJ, Ojeda D, Lakhal B, Braham R, Eggers S, Turbitt E, et al. CITED2 mutations potentially cause idiopathic premature ovarian failure. Transl Res. 2012;160:384–8.

    Article  CAS  PubMed  Google Scholar 

  68. Lakhal B, Ben-Hadj-Khalifa S, Bouali N, Braham R, Hatem E, Saad A. Mutational screening of SF1 and WNT4 in Tunisian women with premature ovarian failure. Gene. 2012;509:298–301.

    Article  CAS  PubMed  Google Scholar 

  69. Chen B, Suo P, Wang B, Wang J, Yang L, Zhou S, et al. Mutation analysis of the WNT4 gene in Han Chinese women with premature ovarian failure. Reprod Biol Endocrinol. 2011;9:75. 7827-9-75.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  70. Mandon-Pepin B, Touraine P, Kuttenn F, Derbois C, Rouxel A, Matsuda F, et al. Genetic investigation of four meiotic genes in women with premature ovarian failure. Eur J Endocrinol. 2008;158:107–15.

    Article  CAS  PubMed  Google Scholar 

  71. Kim S, Pyun JA, Kang H, Kim J, Cha DH, Kwack K. Epistasis between CYP19A1 and ESR1 polymorphisms is associated with premature ovarian failure. Fertil Steril. 2011;95:353–6.

    Article  CAS  PubMed  Google Scholar 

  72. Hens L, Devroey P, Van Waesberghe L, Bonduelle M, Van Steirteghem AC, Liebaers I. Chromosome studies and fertility treatment in women with ovarian failure. Clin Genet. 1989;36:81–91.

    Article  CAS  PubMed  Google Scholar 

  73. Kawano Y, Narahara H, Matsui N, Miyakawa I. Premature ovarian failure associated with a Robertsonian translocation. Acta Obstet Gynecol Scand. 1998;77:467–9.

    CAS  PubMed  Google Scholar 

  74. Oldenburg RA, van Dooren MF, de Graaf B, Simons E, Govaerts L, Swagemakers S, et al. A genome-wide linkage scan in a Dutch family identifies a premature ovarian failure susceptibility locus. Hum Reprod. 2008;23:2835–41.

    Article  CAS  PubMed  Google Scholar 

  75. Kasippillai T, MacArthur DG, Kirby A, Thomas B, Lambalk CB, Daly MJ, et al. Mutations in eIF4ENIF1 are associated with primary ovarian insufficiency. J Clin Endocrinol Metab. 2013;98:E1534–9.

    Article  CAS  PubMed  Google Scholar 

  76. Caburet S, Zavadakova P, Ben-Neriah Z, Bouhali K, Dipietromaria A, Charon C, et al. Genome-wide linkage in a highly consanguineous pedigree reveals two novel loci on chromosome 7 for non-syndromic familial Premature Ovarian Failure. PLoS One. 2012;7:e33412.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  77. Caburet S, Arboleda VA, Llano E, Overbeek PA, Barbero JL, Oka K, et al. Mutant cohesin in premature ovarian failure. N Engl J Med. 2014;370:943–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  78. Yang X, Zhou Y, Peng S, Wu L, Lin HY, Wang S, et al. Differentially expressed plasma microRNAs in premature ovarian failure patients and the potential regulatory function of mir-23a in granulosa cell apoptosis. Reproduction. 2012;144:235–44.

    Article  CAS  PubMed  Google Scholar 

  79. Kuang H, Han D, Xie J, Yan Y, Li J, Ge P. Profiling of differentially expressed microRNAs in premature ovarian failure in an animal model. Gynecol Endocrinol. 2014;30:57–61.

    Article  CAS  PubMed  Google Scholar 

  80. Rah H, Jeon YJ, Lee BE, Kim JO, Shim SH, Lee WS, et al. Association of polymorphisms in microRNA machinery genes (DROSHA, DICER1, RAN, and XPO5) with risk of idiopathic primary ovarian insufficiency in Korean women. Menopause. 2013;20:1067–73.

    Article  PubMed  Google Scholar 

  81. Kang H, Lee SK, Kim MH, Song J, Bae SJ, Kim NK, et al. Parathyroid hormone-responsive B1 gene is associated with premature ovarian failure. Hum Reprod. 2008;23:1457–65.

    Article  CAS  PubMed  Google Scholar 

  82. Kang H, Lee SK, Cho SW, Lee SH, Kwack K. Branched chain alpha-keto acid dehydrogenase, E1-beta subunit gene is associated with premature ovarian failure. Fertil Steril. 2008;89:728–31.

    Article  CAS  PubMed  Google Scholar 

  83. Kang H, Lee SK, Kim MH, Choi H, Lee SH, Kwack K. Acyl-CoA synthetase long-chain family member 6 is associated with premature ovarian failure. Fertil Steril. 2009;91:1339–43.

    Article  CAS  PubMed  Google Scholar 

  84. Qin Y, Sun M, You L, Wei D, Sun J, Liang X, et al. ESR1, HK3 and BRSK1 gene variants are associated with both age at natural menopause and premature ovarian failure. Orphanet J Rare Dis. 2012;7:5. 1172-7-5.

    Article  PubMed Central  PubMed  Google Scholar 

  85. Knauff EA, Franke L, van Es MA, van den Berg LH, van der Schouw YT, Laven JS, et al. Genome-wide association study in premature ovarian failure patients suggests ADAMTS19 as a possible candidate gene. Hum Reprod. 2009;24:2372–8.

    Article  CAS  PubMed  Google Scholar 

  86. Pyun JA, Cha DH, Kwack K. LAMC1 gene is associated with premature ovarian failure. Maturitas. 2012;71:402–6.

    Article  CAS  PubMed  Google Scholar 

  87. Pyun JA, Kang H, Lee SK, Kim MH, Kwack K. Association between polymorphisms in the protein L-isoaspartate (D-aspartate) O-methyltransferase gene and premature ovarian failure. Fertil Steril. 2009;91:1362–5.

    Article  CAS  PubMed  Google Scholar 

  88. Aboura A, Dupas C, Tachdjian G, Portnoi MF, Bourcigaux N, Dewailly D, et al. Array comparative genomic hybridization profiling analysis reveals deoxyribonucleic acid copy number variations associated with premature ovarian failure. J Clin Endocrinol Metab. 2009;94:4540–6.

    Article  CAS  PubMed  Google Scholar 

  89. Quilter CR, Karcanias AC, Bagga MR, Duncan S, Murray A, Conway GS, et al. Analysis \of X chromosome genomic DNA sequence copy number variation associated with premature ovarian failure (POF). Hum Reprod. 2010;25:2139–50.

  90. Zhen XM, Sun YM, Qiao J, Li R, Wang LN, Liu P. Genome-wide copy number scan in Chinese patients with premature ovarian failure. Beijing Da Xue Xue Bao. 2013;45:841–7.

    CAS  PubMed  Google Scholar 

  91. McGuire MM, Bowden W, Engel NJ, Ahn HW, Kovanci E, Rajkovic A. Genomic analysis using high-resolution single-nucleotide polymorphism arrays reveals novel microdeletions associated with premature ovarian failure. Fertil Steril. 2011;95:1595–600.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  92. Jin M, Yu Y, Huang H. An update on primary ovarian insufficiency. Sci China Life Sci. 2012;55:677–86.

    Article  CAS  PubMed  Google Scholar 

  93. Cobo A, Garcia-Velasco JA, Domingo J, Remohi J, Pellicer A. Is vitrification of oocytes useful for fertility preservation for age-related fertility decline and in cancer patients? Fertil Steril. 2013;99:1485–95.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elena Labarta.

Additional information

Capsule

Genetic factors are the most commonly identified cause of Primary Ovarian Insufficiency. This review aims to collect all the genetic abnormalities and genes related with this condition.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fortuño, C., Labarta, E. Genetics of primary ovarian insufficiency: a review. J Assist Reprod Genet 31, 1573–1585 (2014). https://doi.org/10.1007/s10815-014-0342-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-014-0342-9

Keywords

Navigation